0,927  0,002  GST A substrate
0,924  0,003  Eye irritation, high
0,887  0,002  Succinate dehydrogenase inhibitor
0,880  0,003  Skin irritative effect
0,849  0,005  Caspase 9 stimulant
0,772  0,004  Platelet antagonist
0,773  0,009  TNF expression inhibitor
0,756  0,009  CYP2C9 substrate
0,737  0,004  Antimutagenic
0,736  0,005  Lipoprotein disorders treatment
0,731  0,002  GABA C receptor agonist
0,735  0,009  Antihypercholesterolemic
0,713  0,005  Vasodilator, peripheral
0,729  0,026  Antiinflammatory
0,713  0,011  Carcinogenic
0,701  0,005  Antipsoriatic
0,699  0,010  Radioprotector
0,695  0,008  CYP2C19 substrate
0,701  0,016  Teratogen
0,683  0,002  GST P1-1 substrate
0,688  0,016  Embryotoxic
0,680  0,009  Cholesterol antagonist
0,673  0,008  CTGF expression inhibitor
0,671  0,012  Chemoprotective
0,658  0,008  NOS3 expression inhibitor
0,648  0,004  FMO1 substrate
0,649  0,006  Antipruritic, allergic
0,641  0,005  Antiglaucomic
0,646  0,012  Antithrombotic
0,636  0,004  Alpha-N-acetylglucosaminidase inhibitor
0,643  0,014  Aldehyde oxidase inhibitor
0,634  0,005  Hypolipemic
0,623  0,013  Sensitization
0,614  0,004  Antiulcerative
0,629  0,023  Antidiabetic
0,629  0,023  Cyclophilin D inhibitor
0,612  0,011  Cardiovascular analeptic
0,608  0,014  Atherosclerosis treatment
0,604  0,014  Antiallergic
0,600  0,014  Mutagenic
0,600  0,014  Bone diseases treatment
0,586  0,003  Alcohol oxidase inhibitor
0,593  0,011  Cardioprotectant
0,590  0,011  Apoptosis antagonist
0,587  0,011  Histamine release inhibitor
0,585  0,015  CYP1A2 substrate
0,578  0,010  GABA C receptor rho-3 antagonist
0,611  0,047  Apoptosis agonist
0,575  0,013  Antiosteoporotic
0,575  0,014  UGT1A9 substrate
0,562  0,014  AR expression inhibitor
0,550  0,003  Corneal wound healing stimulator
0,549  0,003  GST M1-1 substrate
0,549  0,005  UGT2B4 substrate
0,534  0,002  Alcohol dehydrogenase substrate
0,534  0,004  Abortion inducer
0,560  0,033  CYP3A4 substrate
0,560  0,036  Transcription factor NF kappa B inhibitor
0,529  0,009  Antihypertriglyceridemic
0,534  0,017  Ulceration
0,537  0,022  5 Hydroxytryptamine release stimulant
0,523  0,010  Vasodilator
0,529  0,018  Hepatic disorders treatment
0,529  0,019  Immunomodulator
0,513  0,004  Antihyperlipoproteinemic
0,522  0,018  Antifungal
0,509  0,005  Platelet adhesion inhibitor
0,513  0,010  Antidiabetic symptomatic
0,529  0,026  Immunosuppressant
0,510  0,009  Antihypoxic
0,503  0,003  Gastrin inhibitor
0,524  0,025  5 Hydroxytryptamine release inhibitor
0,510  0,012  UGT1A6 substrate
0,503  0,007  UGT1A3 substrate
0,508  0,014  Antipyretic
0,499  0,006  Phospholipase C inhibitor
0,485  0,005  FMO3 substrate
0,484  0,004  Tyrosine 3 hydroxylase inhibitor
0,478  0,005  UGT2B1 substrate
0,475  0,003  Prostaglandin EP2 antagonist
0,494  0,026  CYP2D6 substrate
0,471  0,004  Antipruritic, non-allergic
0,487  0,022  Antioxidant
0,492  0,030  Stroke treatment
0,471  0,010  Anesthetic general
0,460  0,003  Ferrochelatase inhibitor
0,474  0,018  Hypoglycemic
0,462  0,007  UGT2B7 substrate
0,464  0,010  UGT1A4 substrate
0,463  0,013  Myocardial infarction treatment
0,452  0,004  Prostaglandin antagonist
0,461  0,014  Interleukin 2 agonist
0,464  0,017  Superoxide dismutase inhibitor
0,465  0,020  Antidiabetic (type 2)
0,453  0,010  Flavin-containing monooxygenase substrate
0,446  0,005  Acaricide
0,448  0,009  Antiseptic
0,440  0,002  Fumarate hydratase inhibitor
0,453  0,015  UDP-glucuronosyltransferase substrate
0,441  0,005  DNA polymerase I inhibitor
0,438  0,004  Glutamate dehydrogenase inhibitor
0,447  0,014  Platelet aggregation inhibitor
0,461  0,034  Respiratory analeptic
0,431  0,006  Protein kinase stimulant
0,431  0,009  5 Hydroxytryptamine uptake stimulant
0,470  0,049  Antibacterial
0,434  0,014  UGT1A1 substrate
0,421  0,004  Phospholipase A2 inhibitor
0,440  0,024  Proliferative diseases treatment
0,431  0,016  Peroxidase inhibitor
0,432  0,018  Vascular (periferal) disease treatment
0,440  0,026  NOS2 expression inhibitor
0,424  0,010  Hair growth stimulant
0,416  0,005  Glutathione S-transferase substrate
0,441  0,032  Caspase 3 stimulant
0,435  0,028  ICAM1 expression inhibitor
0,409  0,003  Adenylate kinase inhibitor
0,424  0,018  Angiogenesis stimulant
0,406  0,004  Vanilloid agonist
0,407  0,005  Aldehyde dehydrogenase inhibitor
0,411  0,011  Carcinogenic, group 3
0,419  0,019  DNA synthesis inhibitor
0,413  0,014  Sodium/bile acid cotransporter inhibitor
0,402  0,004  Catalase inhibitor
0,404  0,005  Neurotrophic factor enhancer
0,419  0,022  Radiosensitizer
0,424  0,033  Analeptic
0,422  0,032  Lipoxygenase inhibitor
0,429  0,042  Immunostimulant
0,397  0,015  Antiparkinsonian, rigidity relieving
0,384  0,002  Lysophosphatidic acid 2 receptor antagonist
0,451  0,071  Antiarthritic
0,386  0,011  VCAM1 expression inhibitor
0,377  0,002  Aconitate hydratase inhibitor
0,395  0,019  Interleukin agonist
0,384  0,012  Antiacne
0,397  0,025  Antiparasitic
0,378  0,008  Insulin sensitizer
0,368  0,006  Antihelmintic (Nematodes)
0,393  0,037  Cytotoxic
0,371  0,017  Non-steroidal antiinflammatory agent
0,358  0,005  Antieczematic
0,372  0,020  Antihelmintic
0,360  0,008  CYP2B6 inhibitor
0,359  0,010  Antiparkinsonian, tremor relieving
0,352  0,006  Carcinogenic, group 1
0,375  0,034  Free radical scavenger
0,345  0,003  UGT2B10 substrate
0,344  0,005  Excitatory amino acid transporter EAAC1 inhibitor
0,345  0,007  UGT2B9 substrate
0,342  0,003  Glutamate decarboxylase inhibitor
0,350  0,012  Protein-tyrosine phosphatase inhibitor
0,397  0,064  CYP2C19 inhibitor
0,356  0,023  RNA-directed DNA polymerase inhibitor
0,333  0,005  Porphobilinogen synthase inhibitor
0,331  0,004  Phosphofructokinase-1 inhibitor
0,358  0,033  Chemopreventive
0,359  0,035  Antineoplastic (lymphoma)
0,373  0,049  Antihypertensive
0,359  0,036  Tumour necrosis factor alpha release inhibitor
0,325  0,005  Antispirochetal
0,330  0,013  Liver fibrosis treatment
0,320  0,004  GABA C receptor antagonist
0,331  0,016  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,323  0,008  Cystathionine beta-synthase inhibitor
0,362  0,049  Spasmolytic
0,320  0,008  Antiprotozoal (Coccidial)
0,314  0,005  Uterine stimulant
0,348  0,042  Cytostatic
0,329  0,023  Hepatoprotectant
0,308  0,004  Peroxisome proliferator-activated receptor gamma agonist
0,336  0,034  Nitric oxide antagonist
0,314  0,016  NOS3 expression enhancer
0,304  0,011  Cholesterol synthesis inhibitor
0,305  0,019  Interferon gamma antagonist
0,290  0,005  Triose-phosphate isomerase inhibitor
0,305  0,020  Anesthetic
0,291  0,007  ATPase inhibitor
0,303  0,018  Lipid peroxidase inhibitor
0,304  0,021  Melanin inhibitor
0,288  0,006  Choleretic
0,291  0,011  Cell adhesion inhibitor
0,282  0,005  ABCA1 expression enhancer
0,280  0,004  Keratolytic
0,280  0,004  Vanilloid 1 agonist
0,284  0,009  Expectorant
0,294  0,019  Antiischemic, cerebral
0,277  0,004  Prolactin inhibitor
0,277  0,004  Aldehyde dehydrogenase substrate
0,311  0,039  Antineoplastic (lymphocytic leukemia)
0,275  0,003  Arachidonic acid antagonist
0,292  0,022  Skeletal muscle relaxant
0,276  0,009  Antibacterial (Helicobacter pylori)
0,283  0,020  UGT2B15 substrate
0,275  0,012  Cell wall synthesis inhibitor
0,269  0,007  Arylamine N-Acetyltransferase substrate
0,274  0,013  Protein-tyrosine phosphatase 1B inhibitor
0,265  0,003  GST T1-1 substrate
0,264  0,002  Acyl-CoA dehydrogenase inhibitor
0,279  0,019  Genotoxic
0,294  0,036  Septic shock treatment
0,260  0,005  Argininosuccinate synthase inhibitor
0,275  0,021  Monophenol monooxygenase inhibitor
0,255  0,004  GABA C receptor rho-1 antagonist
0,257  0,006  Gastric antisecretory
0,322  0,071  Vasodilator, coronary
0,277  0,029  Pneumotoxic
0,284  0,036  Antihypotensive
0,254  0,007  Coagulant
0,257  0,011  Neurotrophic factor
0,254  0,009  Toll-Like receptor 2 antagonist
0,335  0,090  Toll-Like receptor agonist
0,269  0,026  Restenosis treatment
0,251  0,008  Contraceptive female
0,250  0,009  Histidine decarboxylase inhibitor
0,247  0,005  Creatine kinase inhibitor
0,311  0,070  Antiischemic
0,298  0,059  Insulysin inhibitor
0,241  0,003  Prostaglandin agonist
0,242  0,005  Adenylate cyclase stimulant
0,247  0,010  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,239  0,003  Prostaglandin F2 alpha antagonist
0,259  0,023  Bone formation stimulant
0,251  0,015  5-Lipoxygenase inhibitor
0,245  0,010  SULT1A1 substrate
0,244  0,009  Antirickettsial
0,340  0,105  15-Lipoxygenase inhibitor
0,244  0,013  GABA C receptor rho-2 antagonist
0,292  0,060  DNA damaging
0,235  0,006  TRPA1 agonist
0,228  0,004  Ornithine decarboxylase inhibitor
0,227  0,004  Transcription factor AP-1 inhibitor
0,265  0,043  Wound healing agent
0,226  0,005  Sphingosine 1-phosphate receptor 5 antagonist
0,245  0,025  Antidote
0,225  0,007  Actinic keratosis treatment
0,236  0,019  SULT1A3 substrate
0,220  0,005  Leukotriene antagonist
0,301  0,085  Multiple sclerosis treatment
0,215  0,002  Lysophosphatidic acid 3 receptor antagonist
0,246  0,035  Lipocortins synthesis antagonist
0,226  0,015  Microtubule formation inhibitor
0,217  0,007  Thioredoxin inhibitor
0,216  0,007  Carbamoyl phosphate synthetase inhibitor
0,212  0,003  Ca2+-transporting ATPase inhibitor
0,221  0,013  Retinopathy treatment
0,210  0,003  Thromboxane synthase inhibitor
0,208  0,001  Glucose-6-phosphate isomerase inhibitor
0,211  0,005  Antiviral (Papilloma)
0,316  0,111  Antineoplastic (breast cancer)
0,222  0,017  Carcinogenic, group 2B
0,232  0,030  CNS active muscle relaxant
0,202  0,004  UGT2B11 substrate
0,241  0,043  Muscle relaxant
0,209  0,011  Mucolytic
0,222  0,024  Antifungal enhancer
0,203  0,005  Antidote, mercury
0,216  0,018  Aminopeptidase B inhibitor
0,205  0,008  Electrolyte absorption antagonist
0,216  0,019  Interleukin 4 antagonist
0,245  0,049  DNA methyltransferase I inhibitor
0,205  0,009  Sphingomyelinase inhibitor
0,200  0,004  Prostaglandin EP3 antagonist
0,245  0,049  Antialcoholic
0,202  0,007  Ornithine carbamoyltransferase inhibitor
0,209  0,013  Growth stimulant
0,204  0,009  Cell adhesion molecule inhibitor
0,202  0,007  Sphingosine 1-phosphate receptor 2 antagonist
0,228  0,033  LDLR expression enhancer
0,198  0,004  Glycine receptor agonist
0,228  0,035  Amylase inhibitor
0,234  0,042  Macular degeneration treatment
0,252  0,061  Interleukin antagonist
0,202  0,012  Photosensitizer
0,199  0,009  Sphingosine 1-phosphate receptor 4 antagonist
0,212  0,023  Alkylator
0,299  0,110  Toll-Like receptor 7 agonist
0,195  0,006  Biliverdin reductase inhibitor
0,244  0,055  Peptidyltransferase inhibitor
0,208  0,019  Farnesoid X receptor antagonist
0,231  0,043  Antieczematic atopic
0,344  0,157  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,290  0,102  Calcium channel activator
0,206  0,019  Antiviral (Poxvirus)
0,200  0,014  Antineoplastic, alkylator
0,205  0,020  Retinoprotector
0,192  0,007  CDC25A inhibitor
0,225  0,041  Thrombolytic
0,188  0,004  Prostaglandin D2 antagonist
0,236  0,052  Antiviral (West Nile virus)
0,238  0,055  Sedative
0,188  0,005  NMDA receptor agonist
0,185  0,003  Retinoid X beta receptor agonist
0,209  0,028  Aldose reductase substrate
0,196  0,015  Mediator release inhibitor
0,273  0,094  Antineoplastic (osteosarcoma)
0,217  0,039  Antipruritic
0,183  0,006  Leukotriene synthesis inhibitor
0,178  0,004  Antiviral (Parainfluenza)
0,247  0,074  Acute neurologic disorders treatment
0,188  0,014  HIV-1 integrase (Overall Integration) inhibitor
0,177  0,004  Thromboxane antagonist
0,175  0,004  Leukotriene B4 antagonist
0,184  0,014  Antiviral (Influenza B)
0,174  0,005  Sphingosine 1-phosphate receptor 4 agonist
0,194  0,026  Chelator
0,207  0,039  Acute respiratory distress syndrome (ARDS) treatment
0,174  0,007  Prostaglandin E2 antagonist
0,186  0,019  Carbonic anhydrase III inhibitor
0,169  0,002  Kainate receptor agonist
0,176  0,010  Toll-Like receptor 4 antagonist
0,177  0,011  Electron transport complex I inhibitor
0,174  0,008  Anabolic
0,204  0,039  Antiviral (Hepatitis C)
0,168  0,004  Nicotinic acid receptor agonist
0,177  0,013  NADH dehydrogenase inhibitor
0,214  0,050  Antiviral (Hepatitis)
0,236  0,074  Cardiodepressant
0,186  0,024  Cyclooxygenase 3 inhibitor
0,199  0,037  Skin whitener
0,165  0,004  Thromboxane A2 antagonist
0,239  0,078  Antineoplastic (liver cancer)
0,169  0,008  Interferon agonist
0,186  0,025  Antineoplastic antimetabolite
0,174  0,014  Selectin antagonist
0,164  0,005  Peroxisome proliferator-activated receptor alpha agonist
0,170  0,012  Transcription factor NF kappa B stimulant
0,185  0,027  Cathepsin H inhibitor
0,193  0,039  Neurotensin receptor agonist
0,174  0,021  Sulfotransferase substrate
0,168  0,018  Caspase 3 inhibitor
0,173  0,023  UDP-glucose 4-epimerase inhibitor
0,158  0,007  Glycine transporter 2 inhibitor
0,218  0,068  DNA methylase inhibitor
0,153  0,003  Retinoid X receptor agonist
0,185  0,036  Antianemic
0,158  0,009  Restless leg syndrome treatment
0,153  0,004  Endocannabinoid uptake inhibitor
0,155  0,006  Glycine receptor antagonist
0,178  0,031  Antifungal (Cryptococcus)
0,185  0,037  Raynaud's phenomenon treatment
0,150  0,003  Retinoid X alpha receptor agonist
0,187  0,041  Pulmonary hypertension treatment
0,189  0,044  Thiol protease inhibitor
0,161  0,016  DOPA decarboxylase inhibitor
0,156  0,012  Aminopeptidase I inhibitor
0,187  0,043  Insulin secretagoues
0,165  0,022  Heat shock protein 70 antagonist
0,190  0,048  Diuretic
0,150  0,008  GABA aminotransferase inhibitor
0,147  0,007  CDC25B inhibitor
0,144  0,004  Squalene synthetase inhibitor
0,151  0,011  Toll-Like receptor 2 agonist
0,142  0,003  Retinoid X gamma receptor agonist
0,155  0,017  Antifungal (Pneumocystis)
0,187  0,049  Interleukin 6 antagonist
0,150  0,011  Lanosterol 14 alpha demethylase inhibitor
0,160  0,022  AMP-activated protein kinase stimulant
0,141  0,003  Prostaglandin E2 agonist
0,140  0,004  Exportin-1 inhibitor
0,189  0,052  Muscular dystrophy treatment
0,148  0,012  Phenylalanine 4-hydroxylase inhibitor
0,148  0,012  Glutathione S-transferase inhibitor
0,139  0,004  Glutamate (mGluR6) antagonist
0,146  0,012  Antifungal (Candida)
0,268  0,135  Antiasthmatic
0,139  0,009  Hyperparathyroidism treatment
0,158  0,029  Antineoplastic antibiotic
0,163  0,035  Gout treatment
0,150  0,023  Calcium antagonist
0,174  0,047  Antidiabetic (type 1)
0,182  0,056  Urolithiasis treatment
0,128  0,002  Prostaglandin D2 agonist
0,137  0,011  ATPase (Vacuolar H+) inhibitor
0,203  0,078  Psychostimulant
0,146  0,022  Alcohol dehydrogenase inhibitor
0,182  0,059  Antineoplastic (bone cancer)
0,127  0,005  Vanilloid 4 agonist
0,185  0,063  Dual specificity phosphatase inhibitor
0,134  0,013  Antimetabolite
0,225  0,104  Amyotrophic lateral sclerosis treatment
0,160  0,039  Antihemorrhagic
0,258  0,138  Antineoplastic (endocrine cancer)
0,207  0,088  Cyclic AMP phosphodiesterase inhibitor
0,123  0,004  Vanilloid 2 antagonist
0,225  0,106  Transcription factor STAT3 inhibitor
0,125  0,007  Interferon inducer
0,148  0,030  Antihelmintic (Fasciola)
0,123  0,005  Phospholipase D inhibitor
0,120  0,003  Prostaglandin EP4 agonist
0,202  0,086  Nitric-oxide synthase stimulant
0,175  0,060  Antiviral (Herpes)
0,149  0,035  Interleukin 8 antagonist
0,123  0,009  Peroxisome proliferator-activated receptor gamma antagonist
0,263  0,149  CYP2C9 inhibitor
0,145  0,033  Anticataract
0,121  0,009  Acetyl-CoA transferase inhibitor
0,134  0,022  Paget's disease treatment
0,115  0,004  Leukotriene B4 receptor 1 antagonist
0,112  0,003  Membrane dipeptidase inhibitor
0,113  0,004  Prostaglandin EP4 antagonist
0,151  0,042  Antiprotozoal (Amoeba)
0,123  0,015  Na+ K+ transporting ATPase inhibitor
0,257  0,150  Antiobesity
0,230  0,122  12-Lipoxygenase inhibitor
0,229  0,123  Metabolic disease treatment
0,128  0,023  Antiviral (Rhinovirus)
0,138  0,034  Sphingosine 1-phosphate receptor 2 agonist
0,135  0,032  Estrogen antagonist
0,127  0,024  Tourette's syndrome treatment
0,128  0,025  Antibiotic
0,117  0,014  Narcotic antagonist
0,165  0,063  Hexokinase inhibitor
0,150  0,048  Antihelmintic (Trematoda)
0,119  0,017  Granulocyte macrophage colony stimulating factor agonist
0,136  0,034  Myasthenia Gravis treatment
0,104  0,003  Prostaglandin EP2 agonist
0,114  0,013  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,173  0,071  Growth hormone agonist
0,126  0,026  Cathepsin G inhibitor
0,109  0,010  Antimycoplasmal
0,104  0,005  Anesthetic inhalation
0,184  0,085  VEGF expression inhibitor
0,106  0,007  SULT2A1 substrate
0,118  0,019  NAT1 substrate
0,108  0,010  Antidote, organophosphates
0,148  0,050  Anesthetic local
0,100  0,002  Lysophosphatidic acid receptor 1 agonist
0,169  0,071  Aldehyde oxidase substrate
0,164  0,067  Neuropathy treatment
0,124  0,028  Carbonic anhydrase VI inhibitor
0,118  0,021  Bile acid receptor antagonist
0,101  0,005  Kainate receptor 2 antagonist
0,134  0,038  Protease inhibitor
0,113  0,019  Antiviral (Hepatitis A)
0,156  0,061  Hemostatic
0,110  0,016  Estrogen-related receptor beta agonist
0,104  0,010  Antiviral (Herpesvirus 3, Human)
0,180  0,087  Growth factor agonist
0,154  0,061  Mannose-6-phosphate isomerase inhibitor
0,097  0,004  Leukotriene C antagonist
0,100  0,007  Kainate receptor antagonist
0,102  0,010  Glutamate (mGluR7) antagonist
0,163  0,071  Cystic fibrosis treatment
0,183  0,092  Pyruvate kinase inhibitor
0,118  0,027  Phosphodiesterase 6D inhibitor
0,103  0,014  GABA B receptor agonist
0,127  0,039  Acetylcholine release stimulant
0,089  0,002  Prostaglandin F2 alpha agonist
0,164  0,077  Catenin beta inhibitor
0,112  0,025  Antiprotozoal activity enhancer
0,137  0,051  Autism spectrum disorders treatment
0,090  0,003  Glutamate (mGluR8) agonist
0,102  0,016  Antidote, heavy metal
0,102  0,017  Anticholelithogenic
0,176  0,091  Antiviral (Influenza)
0,112  0,028  Glutamate release inhibitor
0,089  0,004  Pregnane X receptor antagonist
0,104  0,021  SULT1A2 substrate
0,165  0,082  Toxic, respiratory center
0,087  0,004  Retinoic acid alpha receptor agonist
0,130  0,048  Shock treatment
0,085  0,003  Lysophosphatidic acid 1 receptor antagonist
0,092  0,010  Sphingosine kinase inhibitor
0,085  0,003  Retinoid X receptor antagonist
0,098  0,017  NMDA receptor glycine site agonist
0,098  0,017  Purinergic P2X1 antagonist
0,117  0,036  Carcinogenic, group 2A
0,119  0,038  Uric acid excretion stimulant
0,091  0,010  Sphingosine kinase 2 inhibitor
0,129  0,049  GABA receptor agonist
0,084  0,004  Retinoic acid receptor agonist
0,084  0,005  Prostacyclin antagonist
0,117  0,038  Interleukin 1 beta converting enzyme inhibitor
0,088  0,009  Alpha-mannosidase inhibitor
0,094  0,016  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,083  0,005  Peroxisome proliferator-activated receptor alpha antagonist
0,078  0,002  Lysophosphatidic acid receptor 3 agonist
0,087  0,011  Sphingosine 1-phosphate receptor 5 agonist
0,163  0,087  Phobic disorders treatment
0,102  0,026  Lipase inhibitor
0,123  0,049  NAT2 substrate
0,094  0,019  Maillard reaction inhibitor
0,094  0,020  Carbonic anhydrase stimulant
0,078  0,004  GABA transporter 3 inhibitor
0,101  0,028  Thioredoxin reductase inhibitor
0,090  0,017  Gaucher disease treatment
0,130  0,058  Proteasome inhibitor
0,080  0,008  Peroxisome proliferator-activated receptor delta agonist
0,091  0,019  Human rhinovirus A protease inhibitor
0,091  0,020  Protease 3C (Human rhinovirus) inhibitor
0,077  0,005  Geranyltranstransferase inhibitor
0,074  0,003  Retinoid X alpha receptor antagonist
0,075  0,004  Sodium-dependent vitamin C transporter 2 inhibitor
0,106  0,035  Carbonic anhydrase XIII inhibitor
0,147  0,076  Movement disorders treatment
0,094  0,024  Elastase 1 inhibitor
0,182  0,112  Antiviral (HIV)
0,114  0,044  Folate antagonist
0,097  0,027  HIV-1 integrase (3'-Processing) inhibitor
0,135  0,066  Antiprotozoal (Trichomonas)
0,094  0,025  HIV-1 integrase (Strand Transfer) inhibitor
0,072  0,004  Prostacyclin agonist
0,135  0,067  Cocaine dependence treatment
0,089  0,022  Ribonucleoside-diphosphate reductase inhibitor
0,072  0,004  Kainate receptor 1 antagonist
0,091  0,024  Antitreponemal
0,181  0,114  Antineoplastic (cervical cancer)
0,071  0,004  Leukotriene C4 antagonist
0,095  0,028  HIV-1 integrase inhibitor
0,082  0,016  Sphingosine 1-phosphate receptor 3 antagonist
0,089  0,023  Ribonucleotide reductase inhibitor
0,228  0,162  Inflammatory Bowel disease treatment
0,076  0,010  Adenosine deaminase inhibitor
0,083  0,017  MDM2 inhibitor
0,201  0,136  Transcription factor STAT inhibitor
0,128  0,063  Papain-like protease (SARS coronavirus) inhibitor
0,163  0,099  P-glycoprotein inhibitor
0,074  0,010  Mannosidase inhibitor
0,068  0,005  1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor
0,087  0,024  Antiemphysemic
0,064  0,002  Retinoid X gamma receptor antagonist
0,066  0,005  Kynurenine 3 monooxygenase inhibitor
0,063  0,002  Retinoid X beta receptor antagonist
0,082  0,022  Caspase 9 inhibitor
0,065  0,005  ATP citrate lysase inhibitor
0,064  0,004  Leukotriene B4 receptor 2 antagonist
0,157  0,097  Diabetic nephropathy treatment
0,061  0,003  Prostaglandin H2 antagonist
0,133  0,075  Contraceptive
0,091  0,034  Estrogen receptor alpha antagonist
0,061  0,004  Retinoic acid beta receptor agonist
0,067  0,009  GABA B receptor antagonist
0,095  0,039  3C-Like protease (SARS coronavirus) inhibitor
0,094  0,038  D-Ala-D-Ala ligase inhibitor
0,080  0,023  Aldose reductase inhibitor
0,190  0,135  Huntington's disease treatment
0,062  0,007  GABA transporter 2 inhibitor
0,063  0,008  Glutamate (mGluR3) antagonist
0,095  0,040  mTOR complex 2 inhibitor
0,058  0,004  Retinoic acid receptor antagonist
0,113  0,059  Falcipain 3 inhibitor
0,080  0,025  NMDA 2C receptor antagonist
0,069  0,014  Squalene epoxidase inhibitor
0,058  0,004  Retinoic acid alpha receptor antagonist
0,108  0,054  Xanthine oxidase inhibitor
0,056  0,002  Thromboxane agonist
0,131  0,078  Cytokine production inhibitor
0,173  0,119  Antiprotozoal (Leishmania)
0,086  0,033  Amidase inhibitor
0,107  0,054  Antischistosomal
0,150  0,097  Dual specificity phosphatase 3 inhibitor
0,057  0,005  HMG CoA reductase inhibitor
0,055  0,003  Calcium-independent phospholipase A2 inhibitor
0,070  0,018  Sphingosine 1-phosphate receptor 1 antagonist
0,085  0,033  Carbonic anhydrase VA inhibitor
0,061  0,010  AMPA 4 receptor antagonist
0,069  0,018  Nicotinic alpha3beta2 receptor antagonist
0,136  0,085  Pregnane X receptor agonist
0,060  0,009  Acetyl-CoA transferase 1 inhibitor
0,090  0,040  Nicotinic alpha4beta2 receptor antagonist
0,185  0,135  Antineoplastic (ovarian cancer)
0,095  0,046  Tocolytic
0,058  0,009  Leukotriene D4 antagonist
0,074  0,025  Carbonic anhydrase VB inhibitor
0,059  0,010  Sphingosine kinase 1 inhibitor
0,102  0,054  Potassium channel (Ca-activated) activator
0,057  0,009  Angiotensin AT1 receptor antagonist
0,144  0,097  Hearing loss treatment
0,157  0,110  Sepsis treatment
0,058  0,011  Arginase inhibitor
0,081  0,034  S-adenosyl-L-methionine decarboxylase inhibitor
0,067  0,020  Acetyl-CoA transferase 2 inhibitor
0,081  0,035  Carbonic anhydrase V inhibitor
0,204  0,159  Thyroid hormone antagonist
0,084  0,039  Sphingosine 1-phosphate receptor antagonist
0,068  0,023  Lipocortins synthesis agonist
0,140  0,095  CF transmembrane conductance regulator agonist
0,055  0,010  3-Hydroxyanthranilate 3,4-dioxygenase inhibitor
0,056  0,012  GABA uptake inhibitor
0,091  0,046  Inducible nitric-oxide synthase inhibitor
0,063  0,019  Oleamide hydrolase inhibitor
0,048  0,004  Retinoic acid gamma receptor agonist
0,191  0,147  Antiepileptic
0,052  0,008  Free fatty acid receptor 1 antagonist
0,069  0,026  Fatty acid synthase inhibitor
0,046  0,002  Thromboxane A2 agonist
0,051  0,008  Glutamate (mGluR8) antagonist
0,057  0,014  Guanylate cyclase inhibitor
0,047  0,005  Glutamate (mGluR3) agonist
0,045  0,003  Carbonic anhydrase VIII inhibitor
0,045  0,003  Carbonic anhydrase X inhibitor
0,066  0,024  Ryanodine receptor antagonist
0,051  0,010  Glucagon receptor antagonist
0,055  0,014  Dopamine D5 agonist
0,046  0,005  Elastase 2B inhibitor
0,046  0,005  Elastase 3A inhibitor
0,046  0,005  Elastase 3B inhibitor
0,049  0,009  Vanilloid 3 antagonist
0,169  0,129  Antiviral (Ebola)
0,063  0,024  Dihydroorotate oxidase inhibitor
0,065  0,026  Postcoital contraceptive
0,073  0,034  Uterine relaxant
0,042  0,004  Vanilloid 2 agonist
0,057  0,019  Leukocyte elastase inhibitor
0,046  0,009  Angiotensin II receptor antagonist
0,041  0,005  Nicotinic acid receptor 2 antagonist
0,125  0,089  Pancreatic disorders treatment
0,044  0,007  Prostaglandin EP1 antagonist
0,059  0,022  HCV NS3/NS4A protease inhibitor
0,060  0,024  Plasminogen activator inhibitor antagonist
0,053  0,017  Sphingosine 1-phosphate receptor 1 agonist
0,059  0,024  Heparanase inhibitor
0,143  0,107  Diabetic retinopathy treatment
0,050  0,016  Factor XIIIa inhibitor
0,063  0,028  Glucosylceramidase inhibitor
0,098  0,063  Nitric-oxide synthase inhibitor
0,053  0,018  Glutamate (mGluR4) antagonist
0,053  0,018  Glutamate (mGluR group III) antagonist
0,110  0,076  Menstruation disorders treatment
0,077  0,043  Potassium channel (Tandem pore domain) blocker
0,061  0,027  DNA helicase inhibitor
0,055  0,022  Cholesterol esterase inhibitor
0,076  0,043  Prostaglandin-E synthase inhibitor
0,036  0,004  Isoleucine-tRNA ligase inhibitor
0,066  0,034  Xanthine dehydrogenase inhibitor
0,038  0,006  Glutamate (mGluR1) agonist
0,093  0,060  Antithrombocytopenic
0,057  0,025  CD45 antagonist
0,054  0,023  Purinergic P2Y antagonist
0,090  0,059  Aminoacyl-tRNA synthetase inhibitor
0,101  0,069  HDL-cholesterol increasing
0,043  0,012  Peroxisome proliferator-activated receptor delta antagonist
0,035  0,004  GABA transporter inhibitor
0,116  0,085  Gastritis treatment
0,081  0,050  Macrophage migration inhibitory factor inhibitor
0,192  0,162  Hypoxia-inducible factor 1 alpha inhibitor
0,099  0,069  Carbonic anhydrase XV inhibitor
0,057  0,027  Carbonic anhydrase XIV inhibitor
0,034  0,005  ICAM 1 antagonist
0,045  0,016  Cholesterol absorption inhibitor
0,052  0,023  Sphingosine 1-phosphate receptor agonist
0,041  0,012  Uridine phosphorylase inhibitor
0,067  0,038  Nitric oxide donor
0,190  0,161  Antimycobacterial
0,059  0,030  Adenine nucleotide translocase inhibitor
0,198  0,170  Antineoplastic (brain cancer)
0,051  0,023  Glutamate (mGluR group III) agonist
0,059  0,031  Protein 50S ribosomal subunit inhibitor
0,059  0,031  Cannabinoid CB2 receptor antagonist
0,052  0,024  Cytokine production stimulant
0,032  0,004  Calcium-dependent phospholipase A2 inhibitor
0,109  0,082  Transcription factor STAT6 inhibitor
0,075  0,047  Epoxide hydrolase inhibitor
0,034  0,007  Glutamate (mGluR1a) agonist
0,041  0,013  AMPA 3 receptor antagonist
0,031  0,004  Vitamin D receptor agonist
0,043  0,015  Integrin alpha1beta1 antagonist
0,031  0,004  Neuraminidase (Influenza B) inhibitor
0,046  0,020  5-Alpha-reductase inhibitor
0,031  0,005  G-protein-coupled receptor 120 agonist
0,037  0,012  Lysine carboxypeptidase inhibitor
0,046  0,021  Urate transporter 1 inhibitor
0,078  0,053  NAD(P)H dehydrogenase (quinone) inhibitor
0,051  0,026  Thymidylate synthase inhibitor
0,171  0,147  Calpain inhibitor
0,113  0,088  Allergic rhinitis treatment
0,027  0,003  Glutamate (mGluR6) agonist
0,042  0,019  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,181  0,158  Neuropeptide Y2 antagonist
0,065  0,043  Beta 3 adrenoreceptor antagonist
0,103  0,082  Adenylate cyclase inhibitor
0,032  0,011  Thyroid hormone agonist
0,042  0,021  Cholecystokinin B agonist
0,047  0,026  AICAR transformylase inhibitor
0,028  0,007  Monocarboxylic acid transporter inhibitor
0,028  0,007  Monocarboxylic acid transporter 1 inhibitor
0,084  0,063  Antileprosy
0,042  0,021  Farnesoid X receptor agonist
0,032  0,011  1,3-Beta-glucan synthase inhibitor
0,180  0,160  Prostate cancer treatment
0,036  0,017  Carboxypeptidase B inhibitor
0,033  0,013  Purinergic P2Y15 antagonist
0,047  0,028  Neuraminidase (Influenza A) inhibitor
0,037  0,018  Glutamate (mGluR4) agonist
0,048  0,030  Farnesyltransferase inhibitor
0,032  0,014  LFA antagonist
0,029  0,012  Excitatory amino acid transporter 2 inhibitor
0,021  0,004  GABA transporter 1 inhibitor
0,022  0,006  Telomerase stimulant
0,019  0,003  Immunosuppressant Cyclosporine-like
0,022  0,006  Methylmalonyl-CoA mutase inhibitor
0,185  0,169  Thyroid hormone beta antagonist
0,059  0,043  Cannabinoid CB1 receptor agonist
0,172  0,156  Antineoplastic (pancreatic cancer)
0,019  0,004  Calcineurin inhibitor
0,026  0,011  GRP78 expression inhibitor
0,024  0,009  Excitatory amino acid transporter 3 inhibitor
0,019  0,005  Retinoic acid beta receptor antagonist
0,025  0,011  Integrin beta5 antagonist
0,054  0,040  Angiotensin-converting enzyme inhibitor
0,018  0,004  Retinoic acid receptor gamma antagonist
0,040  0,026  VCAM-1 antagonist
0,029  0,015  Hedgehog signaling activator
0,035  0,022  Carnitine palmitoyltransferase inhibitor
0,040  0,026  VCAM antagonist
0,094  0,080  Antiprotozoal (Toxoplasma)
0,035  0,022  Carnitine palmitoyltransferase 1 inhibitor
0,022  0,009  Caspase 8 inhibitor
0,019  0,006  Angiotensin AT1B receptor antagonist
0,165  0,152  5 Hydroxytryptamine 3E antagonist
0,187  0,175  Antileukemic
0,020  0,008  Vesicular glutamate transport inhibitor
0,044  0,032  Dihydroorotase inhibitor
0,020  0,009  Ileal bile acid transport inhibitor
0,035  0,024  Phosphoglycerate kinase inhibitor
0,105  0,094  Cyclooxygenase 1 inhibitor
0,021  0,010  Apical sodium codependent bile acid transporter inhibitor
0,030  0,019  Liver X receptor beta antagonist
0,020  0,010  Free fatty acid receptor 1 agonist
0,028  0,018  NMDA 2D receptor antagonist
0,048  0,039  Prolyl endopeptidase inhibitor
0,056  0,047  Androgen agonist
0,215  0,206  Antineoplastic (small cell lung cancer)
0,030  0,021  Peptide deformylase inhibitor
0,015  0,006  Carbonic anhydrase XI inhibitor
0,047  0,038  Bombesin 2 receptor antagonist
0,021  0,012  5-Alpha-reductase 2 inhibitor
0,093  0,085  Antiinfertility, female
0,037  0,028  NMDA receptor subunit 3A antagonist
0,035  0,026  Ceramide glucosyltransferase inhibitor
0,040  0,032  Oxytocin agonist
0,048  0,040  Diacylglycerol O-acyltransferase inhibitor
0,015  0,007  1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor
0,031  0,024  Methionyl aminopeptidase 1 inhibitor
0,044  0,037  GP IIb/IIIa receptor antagonist
0,018  0,012  Aminopeptidase A inhibitor
0,020  0,014  Toll-Like receptor 8 agonist
0,028  0,022  Estrogen-related receptor gamma antagonist
0,038  0,033  Thymidine kinase inhibitor
0,076  0,071  Antineoplastic alkaloid
0,037  0,031  Dihydropteroate synthase inhibitor
0,010  0,005  Folate transporter 1 inhibitor
0,090  0,084  Estrogen receptor beta antagonist
0,040  0,035  NMDA receptor subunit 3B antagonist
0,076  0,071  Caspase 7 inhibitor
0,020  0,016  Purinergic P2T antagonist
0,038  0,033  Liver X receptor alpha agonist
0,117  0,112  Antiviral (Influenza A)
0,055  0,050  Neuraminidase inhibitor
0,042  0,038  Adenylate cyclase 1 inhibitor
0,015  0,011  Purinergic P2Y1 agonist
0,021  0,017  Angiotensin AT1A receptor antagonist
0,052  0,049  Immunoglobulin Fc receptor antagonist
0,017  0,013  Nicotinic acid receptor 1 antagonist
0,112  0,109  Cyclooxygenase inhibitor
0,030  0,027  Calcitonin receptor agonist
0,016  0,013  Excitatory amino acid transporter 1 inhibitor
0,020  0,018  Geranylgeranyltransferase inhibitor
0,020  0,018  Purinergic P2Y12 antagonist
0,099  0,097  Antiviral (Coronavirus)
0,099  0,097  Antiviral (SARS coronavirus)
0,025  0,023  AMPA 1 receptor antagonist
0,247  0,245  Antineoplastic (solid tumors)
0,134  0,133  3C-like protease (Human coronavirus) inhibitor
0,031  0,030  Melatonin receptor 1A agonist
0,024  0,023  Hypoxanthine phosphoribosyltransferase inhibitor
0,045  0,044  Dopamine beta hydroxylase inhibitor
0,033  0,033  Tryptophan 5 hydroxylase inhibitor
0,016  0,016  CXC chemokine 5 receptor antagonist
0,022  0,022  Methionyl aminopeptidase 2 inhibitor
0,077  0,077  Antiviral (Dengue virus)

